Muhlenkamp & Co Inc
- SEC CIK
- 0001133219
- Latest filing
- Aug 17, 2026
BMY holding history
Bristol Myers Squibb Co in every 13F filed by Muhlenkamp & Co Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BMY overviewAll 13F holders of BMYFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −135,045−100.0% | Sold out | Holders |
| Q1 2024 | 135,045 | $7.32M | 2.1% | +3,285+2.5% | Added | Holders |
| Q4 2023 | 131,760 | $6.76M | 2.2% | +2,028+1.6% | Added | Holders |
| Q3 2023 | 129,732 | $7.53M | 2.6% | +163+0.1% | Added | Holders |
| Q2 2023 | 129,569 | $8.29M | 2.9% | – | No prior filing | Holders |
| Q1 2023 | – | – | – | – | Not filed | Holders |
| Q4 2022 | 128,950 | $9.28M | 3.9% | +197+0.2% | Added | Holders |
| Q3 2022 | 128,753 | $9.15M | 4.1% | +1,197+0.9% | Added | Holders |
| Q2 2022 | 127,556 | $9.82M | 4.6% | +650+0.5% | Added | Holders |
| Q1 2022 | 126,906 | $9.27M | 3.2% | +919+0.7% | Added | Holders |
| Q4 2021 | 125,987 | $7.86M | 2.7% | +568+0.5% | Added | Holders |
| Q3 2021 | 125,419 | $7.42M | 2.8% | −204−0.2% | Reduced | Holders |
| Q2 2021 | 125,623 | $8.39M | 3.1% | +204+0.2% | Added | Holders |
| Q1 2021 | 125,419 | $8.65M | 3.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.